The following table shows the list of Horizon 2020 projects developed by "BOEHRINGER INGELHEIM INTERNATIONALGMBH". Projects are ordered by starting date.
Click on table headers to rearrange data.
# | acronym | programme | role | EC contrib. | start | views |
---|---|---|---|---|---|---|
1 | ADAPT-SMART | H2020-EU.3.1.7.13. | participant | 0.00 | 2015-07-01 | 688 |
2 | PRISM | H2020-EU.3.1.7. | participant | 0.00 | 2016-04-01 | 829 |
3 | BEAt-DKD | H2020-EU.3.1.7. | participant | 0.00 | 2016-09-01 | 1457 |
4 | TransQST | H2020-EU.3.1.7. | participant | 0.00 | 2017-01-01 | 893 |
5 | DO-IT | H2020-EU.3.1.7. | participant | 0.00 | 2017-02-01 | 1014 |
6 | EQIPD | H2020-EU.3.1.7. | participant | 0.00 | 2017-10-01 | 753 |
7 | eTRANSAFE | H2020-EU.3.1.7. | participant | 0.00 | 2017-09-01 | 869 |
8 | LITMUS | H2020-EU.3.1.7. | participant | 0.00 | 2017-11-01 | 1039 |
9 | ReSOLUTE | H2020-EU.3.1.7. | participant | 0.00 | 2018-07-01 | 329 |
10 | FAIRplus | H2020-EU.3.1.7. | participant | 0.00 | 2019-01-01 | 281 |
11 | BIOMAP | H2020-EU.3.1.7. | participant | 0.00 | 2019-04-01 | 315 |
12 | MELLODDY | H2020-EU.3.1.7. | participant | 0.00 | 2019-06-01 | 390 |
13 | Trials@Home | H2020-EU.3.1.7. | participant | 0.00 | 2019-09-01 | 307 |
totale | 0.00 |
This organization collaborated with partners in 23 countries.
Within the project ADAPT-SMART this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | CH | SHIRE | SHIRE INTERNATIONAL GMBH (PRC) |
participant | UK | AbbVie | AbbVie Ltd (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | IT | AIFA | AGENZIA ITALIANA DEL FARMACO (PRC) |
participant | FR | Lysogene | LYSOGENE (PRC) |
participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
participant | UK | Astellas | ASTELLAS PHARMA EUROPE LTD (PRC) |
participant | NL | ZIN | ZORGINSTITUUT NEDERLAND (PUB) |
participant | FR | IPSEN | IPSEN INNOVATION SAS (PRC) |
participant | FR | HAS | HAUTE AUTORITE DE SANTE (PUB) |
participant | FR | EURORDIS | EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION (OTH) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
participant | US | BMS | BRISTOL-MYERS SQUIBB COMPANY CORP (PRC) |
participant | BE | Amgen | AMGEN (PRC) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | UK | EMA | THE EUROPEAN MEDICINES AGENCY (PUB) |
coordinator | NL | LYGATURE | STICHTING LYGATURE (OTH) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | DE | Bayer | Bayer Pharma AG (PRC) |
participant | US | MIT | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (HES) |
participant | UK | PFIZER | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | DK | DHMA | SUNDHEDSSTYRELSEN (PUB) |
participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | DK | Lundbeck | H. LUNDBECK AS (PRC) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
Within the project PRISM this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | NL | VUmc | STICHTING VUMC (REC) |
participant | NL | ECNP | STICHTING BURO ECNP (OTH) |
participant | NL | DTID | DRUG TARGET ID BV (PRC) |
participant | FR | BIOTRIAL | BIOTRIAL (PRC) |
participant | UK | SBG | SBGNEURO LTD (PRC) |
participant | UK | P1vital | P1VITAL LIMITED (PRC) |
participant | UK | Takeda EU | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | DE | concentris | Concentris Research Management GmbH (PRC) |
participant | BE | EUFAMI | EUROPESE FEDERATIE VAN FAMILIEVERENIGINGEN VAN PSYCHIATRISCH ZIEKE PERSONEN IVZW (OTH) |
participant | ES | CIBER | CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED M.P. (REC) |
participant | UK | ELI LILLY | Eli Lilly and Company Limited (PRC) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | CH | NOV | NOVARTIS PHARMA AG (PRC) |
participant | UK | UNEXE | THE UNIVERSITY OF EXETER (HES) |
participant | NL | UMCU | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
participant | NL | EMC | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
coordinator | NL | RUG | RIJKSUNIVERSITEIT GRONINGEN (HES) |
participant | NL | LUMC | ACADEMISCH ZIEKENHUIS LEIDEN (HES) |
participant | NL | RUMC | STICHTING KATHOLIEKE UNIVERSITEIT (HES) |
participant | IT | UNIBO | ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA (HES) |
Within the project BEAt-DKD this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | US | JDRF | JDRF INTERNATIONAL (REC) |
participant | US | AbbVie | ABBVIE INC (PRC) |
participant | DE | Lipotype | LIPOTYPE (PRC) |
participant | FI | UEF | ITA-SUOMEN YLIOPISTO (HES) |
participant | NL | Astellas | ASTELLAS PHARMA EUROPE BV (PRC) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | DE | SANOFI | SANOFI-AVENTIS DEUTSCHLAND GMBH (PRC) |
participant | DE | Bayer | Bayer Pharma AG (PRC) |
participant | FR | CHUB | CHU HOPITAUX DE BORDEAUX (HES) |
participant | CH | SIB | SIB INSTITUT SUISSE DE BIOINFORMATIQUE (REC) |
participant | IT | IRFMN | ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI (REC) |
participant | IT | UBA | UNIVERSITA DEGLI STUDI DI BARI ALDO MORO (HES) |
participant | US | UNIVERSITY OF MICHIGAN THE REGENTS OF THE UNIVERSITY OF MICHIGAN | UNIVERSITY OF MICHIGAN THE REGENTS OF THE UNIVERSITY OF MICHIGAN (HES) |
participant | AT | MUI | MEDIZINISCHE UNIVERSITAT INNSBRUCK (HES) |
participant | DE | UKE | UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF (HES) |
participant | UK | UNEXE | THE UNIVERSITY OF EXETER (HES) |
participant | DE | UKER | UNIVERSITATSKLINIKUM ERLANGEN (HES) |
participant | DE | UKLFR | UNIVERSITAETSKLINIKUM FREIBURG (HES) |
participant | DE | RCI | KLINIKUM DER UNIVERSITAET REGENSBURG (HES) |
coordinator | SE | LU | LUNDS UNIVERSITET (HES) |
participant | FI | UTU | TURUN YLIOPISTO (HES) |
participant | UK | UHULL | UNIVERSITY OF HULL (HES) |
participant | NL | UMCG | ACADEMISCH ZIEKENHUIS GRONINGEN (HES) |
participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
participant | UK | UoB | UNIVERSITY OF BRISTOL (HES) |
participant | UK | UNIVLEEDS | UNIVERSITY OF LEEDS (HES) |
participant | UK | UNIVDUN | UNIVERSITY OF DUNDEE (HES) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
participant | AT | MUW | MEDIZINISCHE UNIVERSITAET WIEN (HES) |
participant | FI | UH | HELSINGIN YLIOPISTO (HES) |
Within the project TransQST this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | ABBVIE | ABBVIE DEUTSCHLAND GMBH & CO KG (PRC) |
participant | NL | Oc | OCELLO BV (PRC) |
participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | DE | IFADO | FORSCHUNGSGESELLSCHAFT FUR ARBEITSPHYSIOLOGIE UND ARBEITSSCHUTZ E.V. (HES) |
participant | UK | SIMCYP | CERTARA UK LIMITED (PRC) |
participant | ES | IMIM | FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM (REC) |
participant | FI | ORION | ORION OYJ (PRC) |
participant | DE | UKL-HD | UNIVERSITATSKLINIKUM HEIDELBERG (HES) |
participant | AT | UW-APRI | UNIVERSITAT WIEN (HES) |
participant | DE | UKA | UNIVERSITAETSKLINIKUM AACHEN (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | NL | ULEI | UNIVERSITEIT LEIDEN (HES) |
participant | NL | UM | UNIVERSITEIT MAASTRICHT (HES) |
coordinator | UK | UOL | THE UNIVERSITY OF LIVERPOOL (HES) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
participant | DE | EMBL | EUROPEAN MOLECULAR BIOLOGY LABORATORY (REC) |
participant | NL | ERASMUS | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
Within the project DO-IT this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | UK | HIQ | HEALTH IQ LIMITED (PRC) |
participant | UK | ABPI | THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY (OTH) |
participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | SE | IHE | IHE, INSTITUTET FOR HALSO- OCH SJUKVARDSEKONOMI AKTIEBOLAG (PRC) |
participant | NO | NoMA | STATENS LEGEMIDDELVERK (PUB) |
participant | CH | Celgene | CELGENE MANAGEMENT SARL (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
participant | SE | TLV | TANDVARDS-OCH LAKEMEDELSFORMANSVERKET (PUB) |
participant | ES | FI | ASOCIACION NACIONAL EMPRESARIAL DE LA INDUSTRIA FARMACEUTICA (OTH) |
participant | DE | VFA | VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV (OTH) |
participant | BE | EMSP | THE EUROPEAN MULTIPLE SCLEROSIS PLATFORM AISBL (OTH) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | BE | ECPC | EUROPEAN CANCER PATIENT COALITION (OTH) |
participant | DE | TMF | TMF - TECHNOLOGIE UND METHODENPLATTFORM FUR DIE VERNETZTE MEDIZINISCHE FORSCHUNG EV (REC) |
participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
participant | BE | Amgen | AMGEN (PRC) |
participant | UK | ELI LILLY | Eli Lilly and Company Limited (PRC) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | DE | InterSystems | INTERSYSTEMS GMBH (PRC) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | NO | NIPH | FOLKEHELSEINSTITUTTET (REC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | CH | NOV | NOVARTIS PHARMA AG (PRC) |
participant | IT | CERGAS | UNIVERSITA COMMERCIALE LUIGI BOCCONI (HES) |
participant | HU | SU | SEMMELWEIS EGYETEM (HES) |
coordinator | UK | LSE | LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | Novo | NOVO NORDISK A/S (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | UK | ULIV | THE UNIVERSITY OF LIVERPOOL (HES) |
participant | UK | Imperial | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
Within the project EQIPD this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | BE | Arlenda | PHARMALEX BELGIUM (PRC) |
participant | US | SE | SCIENCE EXCHANGE, INC. (PRC) |
participant | BE | Arlenda | ARLENDA SA (PRC) |
participant | DE | PAASP | PAASP GMBH (PRC) |
participant | NL | ECNP | STICHTING BURO ECNP (OTH) |
participant | US | PGI | PSYCHOGENICS INC (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | US | ABBVIE | ABBVIE INC (PRC) |
participant | FR | Porsolt | PORSOLT SAS (PRC) |
participant | DE | UMC-Mainz | UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAET MAINZ (HES) |
participant | DE | concentris | Concentris Research Management GmbH (PRC) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | NL | NOLDUS | NOLDUS INFORMATION TECHNOLOGY BV (PRC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | NL | Sylics | SYNAPTOLOGICS BV (PRC) |
participant | CH | NOV | NOVARTIS PHARMA AG (PRC) |
participant | FI | ORION | ORION OYJ (PRC) |
participant | UK | UniAbdn | THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN (HES) |
participant | FR | Servier | INSTITUT DE RECHERCHES SERVIER (PRC) |
coordinator | UK | UEDIN | THE UNIVERSITY OF EDINBURGH (HES) |
participant | CH | UBERN | UNIVERSITAET BERN (HES) |
participant | DE | LMU MUENCHEN | LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (HES) |
participant | NL | RUG | RIJKSUNIVERSITEIT GRONINGEN (HES) |
participant | DE | EKUT | EBERHARD KARLS UNIVERSITAET TUEBINGEN (HES) |
participant | NL | RUMC | STICHTING KATHOLIEKE UNIVERSITEIT (HES) |
participant | DE | CHARITE | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
participant | UK | Imperial | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |
Within the project eTRANSAFE this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | JP | Eisai | EISAI CO LTD (PRC) |
participant | UK | Clarivate | CLARIVATE ANALYTICS (UK) LIMITED (PRC) |
participant | UK | PDS | PDS COMPUTER SOFTWARE LIMITED (PRC) |
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | US | AbbVie | ABBVIE INC (PRC) |
participant | UK | OPTIBRIUM | OPTIBRIUM LIMITED (PRC) |
participant | FR | IPSEN | IPSEN INNOVATION SAS (PRC) |
participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | UK | LL | LHASA LIMITED (REC) |
participant | DE | SANOFI | SANOFI-AVENTIS DEUTSCHLAND GMBH (PRC) |
participant | DE | MN | MOLECULAR NETWORKS GMBH COMPUTERCHEMIE (PRC) |
participant | UK | LJMU | LIVERPOOL JOHN MOORES UNIVERSITY (HES) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | UK | SIMCYP | CERTARA UK LIMITED (PRC) |
coordinator | ES | IMIM | FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM (REC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | AT | UW-APRI | UNIVERSITAT WIEN (HES) |
participant | ES | UPF | UNIVERSIDAD POMPEU FABRA (HES) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | NL | ULEI | UNIVERSITEIT LEIDEN (HES) |
participant | DE | Fraunhofer | FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (REC) |
participant | DE | EMBL | EUROPEAN MOLECULAR BIOLOGY LABORATORY (REC) |
participant | NL | ERASMUS | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
Within the project LITMUS this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | FR | ECHO | ECHOSENS (PRC) |
participant | SG | HI | HISTOINDEX PTE LTD (PRC) |
participant | US | RESO | RESOUNDANT, INC. (PRC) |
participant | UK | ICPT | INTERCEPT PHARMA EUROPE LTD (PRC) |
participant | DK | Ellegaard | ELLEGAARD GOTTINGEN MINIPIGS AS (PRC) |
participant | IL | EXA | EXALENZ BIOSCIENCE LTD (PRC) |
participant | SE | Antaros | ANTAROS MEDICAL AB (PRC) |
participant | DK | NB | NORDIC BIOSCIENCE A/S (PRC) |
participant | UK | PERS | PERSPECTUM LTD (PRC) |
participant | CH | EASL | EUROPEAN ASSOCIATION FOR THE STUDYOF THE LIVER (OTH) |
participant | UK | AGN | ALLERGAN LIMITED (PRC) |
participant | FR | ICAN | INST CARDIOMETABOLISME NUTRITION ICAN (REC) |
participant | UK | Takeda | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | ES | OWL | ONE WAY LIVER SL (PRC) |
participant | DK | NB | NORDIC BIOSCIENCE COMPOUND DEVELOPMENT A/S (PRC) |
participant | PT | FFUL | Faculdade de Farmácia da Universidade de Lisboa (HES) |
participant | US | GIL | GILEAD SCIENCES INC (PRC) |
participant | DE | UMCM | UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAET MAINZ (HES) |
participant | US | BMS | BRISTOL-MYERS SQUIBB COMPANY CORP (PRC) |
participant | BE | UZA | UNIVERSITAIR ZIEKENHUIS ANTWERPEN (REC) |
participant | DE | UKW | UNIVERSITAETSKLINIKUM WUERZBURG - KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT (HES) |
participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
participant | DE | SANOFI | SANOFI-AVENTIS DEUTSCHLAND GMBH (PRC) |
participant | US | SOMA | SOMALOGIC INC (PRC) |
participant | US | RTI-HS | RESEARCH TRIANGLE INSTITUTE (REC) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | LU | LIH | LUXEMBOURG INSTITUTE OF HEALTH (REC) |
participant | NL | AMC | ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM (HES) |
participant | ES | CIC | ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS (REC) |
participant | ES | SAS | SERVICIO ANDALUZ DE SALUD (PUB) |
participant | EL | NKUA | ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON (HES) |
participant | FR | APHP-SAMU | ASSISTANCE PUBLIQUE HOPITAUX DE PARIS (REC) |
participant | SE | ORU | OREBRO UNIVERSITY (HES) |
participant | FR | GNFT | GENFIT (PRC) |
participant | UK | IXS | IXSCIENT LIMITED (PRC) |
participant | IT | UNIPA | UNIVERSITA DEGLI STUDI DI PALERMO (HES) |
participant | CH | NVS | NOVARTIS PHARMA AG (PRC) |
participant | FR | UA | UNIVERSITE D'ANGERS (HES) |
participant | SE | LIU | LINKOPINGS UNIVERSITET (HES) |
participant | IT | UNITO | UNIVERSITA DEGLI STUDI DI TORINO (HES) |
participant | PT | FML | FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA (HES) |
participant | DE | UKAACHEN | UNIVERSITAETSKLINIKUM AACHEN (HES) |
participant | UK | BIM | THE UNIVERSITY OF BIRMINGHAM (HES) |
participant | NL | UMC UTRECHT | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
participant | IT | UCSC | UNIVERSITA CATTOLICA DEL SACRO CUORE (HES) |
participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
participant | SE | AZ | ASTRAZENECA AB (PRC) |
participant | CH | UB | UNIVERSITAET BERN (HES) |
participant | UK | UoN | THE UNIVERSITY OF NOTTINGHAM (HES) |
participant | UK | UCAM | THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE (HES) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
coordinator | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
participant | AT | MUW | MEDIZINISCHE UNIVERSITAET WIEN (HES) |
participant | FI | UH | HELSINGIN YLIOPISTO (HES) |
participant | IT | UMIL | UNIVERSITA DEGLI STUDI DI MILANO (HES) |
Within the project ReSOLUTE this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | CH | VP | VIFOR (INTERNATIONAL) AG (PRC) |
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | UK | PFIZER | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | IT | AXXAM | AXXAM SPA (PRC) |
coordinator | AT | CeMM | CEMM - FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN GMBH (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | AT | UW-APRI | UNIVERSITAT WIEN (HES) |
participant | UK | UNIMAN | THE UNIVERSITY OF MANCHESTER (HES) |
participant | NL | ULEI | UNIVERSITEIT LEIDEN (HES) |
participant | UK | UOL | THE UNIVERSITY OF LIVERPOOL (HES) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
participant | DE | MPG | MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV (REC) |
Within the project FAIRplus this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | BAY | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | UK | PHACTS | OPEN PHACTS FOUNDATION LBG (REC) |
participant | NL | The Hyve | THE HYVE BV (PRC) |
participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
participant | NL | Lygature | STICHTING LYGATURE (OTH) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | ES | IMIM | FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM (REC) |
participant | CH | SIB | SIB INSTITUT SUISSE DE BIOINFORMATIQUE (REC) |
participant | ES | BSC | BARCELONA SUPERCOMPUTING CENTER - CENTRO NACIONAL DE SUPERCOMPUTACION (REC) |
participant | CH | NVS | NOVARTIS PHARMA AG (PRC) |
participant | FR | UPS-IRIT | UNIVERSITE PAUL SABATIER TOULOUSE III (HES) |
participant | UK | HWU | HERIOT-WATT UNIVERSITY (HES) |
participant | LU | UNILU | UNIVERSITE DU LUXEMBOURG (HES) |
participant | UK | UNIMAN | THE UNIVERSITY OF MANCHESTER (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | SE | AZ | ASTRAZENECA AB (PRC) |
participant | NL | UM | UNIVERSITEIT MAASTRICHT (HES) |
participant | DE | FHG | FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (REC) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
coordinator | DE | EMBL | EUROPEAN MOLECULAR BIOLOGY LABORATORY (REC) |
participant | UK | Imperial | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |
Within the project BIOMAP this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | FI | TUT | TAMPEREEN KORKEAKOULUSAATIO SR (HES) |
participant | LU | ITTM | INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE (ITTM) SA (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | DK | LEO PHARMA | LEO PHARMA AS (PRC) |
participant | DK | COPSAC | DEN SELVEJENDE INSTITUTION DANSK BORNEASTMA CENTER (OTH) |
participant | FI | UEF | ITA-SUOMEN YLIOPISTO (HES) |
participant | DE | SANOFI | SANOFI-AVENTIS DEUTSCHLAND GMBH (PRC) |
participant | UK | PFE | PFIZER LIMITED (PRC) |
participant | NL | AMC | ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM (HES) |
participant | DE | HS | HAHN-SCHICKARD-GESELLSCHAFT FUER ANGEWANDTE FORSCHUNG E.v. (REC) |
participant | AT | AIT | AIT AUSTRIAN INSTITUTE OF TECHNOLOGY GMBH (REC) |
participant | CH | CHUV | CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS (PUB) |
participant | DE | EURICE | EURICE EUROPEAN RESEARCH AND PROJECT OFFICE GMBH (PRC) |
coordinator | DE | CAU | CHRISTIAN-ALBRECHTS-UNIVERSITAET ZU KIEL (HES) |
participant | IE | TCD | THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN (HES) |
participant | DE | UDUS | HEINRICH-HEINE-UNIVERSITAET DUESSELDORF (HES) |
participant | DE | UKE | UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF (HES) |
participant | AT | UNIVIE | UNIVERSITAT WIEN (HES) |
participant | DE | TUM-MED | KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN (HES) |
participant | LU | uni.lu | UNIVERSITE DU LUXEMBOURG (HES) |
participant | EE | UTARTU | TARTU ULIKOOL (HES) |
participant | FI | UTA | TAMPEREEN YLIOPISTO (HES) |
participant | UK | LSHTM | LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER (HES) |
participant | UK | UNIVBRIS | UNIVERSITY OF BRISTOL (HES) |
participant | UK | UNIVDUN | UNIVERSITY OF DUNDEE (HES) |
participant | DE | TUM | TECHNISCHE UNIVERSITAET MUENCHEN (HES) |
participant | SE | KI | KAROLINSKA INSTITUTET (HES) |
participant | UK | KCL | KING'S COLLEGE LONDON (HES) |
participant | NL | LUMC | ACADEMISCH ZIEKENHUIS LEIDEN (HES) |
participant | DK | UCPH | KOBENHAVNS UNIVERSITET (HES) |
participant | NL | RUMC | STICHTING KATHOLIEKE UNIVERSITEIT (HES) |
Within the project MELLODDY this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | AmgenResMunich | AMGEN RESEARCH (MUNICH) GMBH (PRC) |
participant | FR | Iktos | IKTOS (PRC) |
participant | DE | Loodse GmbH | LOODSE GMBH (PRC) |
participant | FR | SubstraF | SUBSTRA (OTH) |
coordinator | FR | OWKIN | OWKIN FRANCE (PRC) |
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | CH | NVIDIA SWISS AG | NVIDIA SWITZERLAND AG (PRC) |
participant | NL | Astellas | ASTELLAS PHARMA EUROPE BV (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | HU | BME | BUDAPESTI MUSZAKI ES GAZDASAGTUDOMANYI EGYETEM (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | FR | Servier | INSTITUT DE RECHERCHES SERVIER (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | BE | KUL | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
Within the project Trials@Home this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | FR | IQVIA | IQVIA RDS FRANCE (PRC) |
participant | BE | Covance | COVANCE CLINICAL AND PERIAPPROVAL SERVICES (PRC) |
participant | UK | MRN | MEDICAL RESEARCH NETWORK LIMITED (PRC) |
participant | UK | eClinicalHealth | ECLINICALHEALTH LTD (PRC) |
participant | NL | MLCF | STICHTING MLC FOUNDATION (OTH) |
participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | IL | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LIMITED (PRC) |
participant | FR | DREEM | DREEM (PRC) |
participant | NL | UPPMD | STICHTING UNITED PARENT PROJECTS MUSCULAR DYSTROPHY (OTH) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | UK | Allergan | ALLERGAN LIMITED (PRC) |
participant | BE | VT | VITAL TRANSFORMATION (PRC) |
participant | CH | Medtronic | MEDTRONIC INTERNATIONAL TRADING SARL (PRC) |
participant | ES | FISABIO | FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA (REC) |
participant | UK | Takeda | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | NL | JCR | JULIUS CLINICAL RESEARCH BV (PRC) |
participant | NL | Lygature | STICHTING LYGATURE (OTH) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | EL | CERTH | ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS (REC) |
participant | AT | JOANNEUM | FH JOANNEUM GESELLSCHAFT MBH (HES) |
participant | CH | Novartis | NOVARTIS PHARMA AG (PRC) |
participant | DK | SDU | SYDDANSK UNIVERSITET (HES) |
coordinator | NL | UMCU | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
participant | SE | AZ | ASTRAZENECA AB (PRC) |
participant | BE | IDF Europe | FEDERATION INTERNATIONALE DU DIABETE REGION EUROPE AISBL (OTH) |
participant | UK | UNIVDUN | UNIVERSITY OF DUNDEE (HES) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
participant | NL | UU | UNIVERSITEIT UTRECHT (HES) |